SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma informs about press release

21 Aug 2024 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksans Pharma Limited’s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products’.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

179.35 -1.15 (-0.64%)
17-Apr-2026 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.85
Dr. Reddys Lab 1229.65
Cipla 1237.10
Zydus Lifesciences 944.80
Lupin 2313.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×